189 related articles for article (PubMed ID: 32322592)
21. Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemia.
Baragaño Raneros A; Rodriguez RM; Bernardo Flórez A; Palomo P; Colado E; Minguela A; Suárez Álvarez B; López-Larrea C
Oncoimmunology; 2021 Mar; 10(1):1897294. PubMed ID: 33796404
[TBL] [Abstract][Full Text] [Related]
22. B7-H6 expression in human hepatocellular carcinoma and its clinical significance [corrected].
Chen L; Feng J; Xu B; Zhou Y; Zheng X; Wu C; Jiang J
Cancer Cell Int; 2018; 18():126. PubMed ID: 30186042
[TBL] [Abstract][Full Text] [Related]
23. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
Jin T; Li D; Yang T; Liu F; Kong J; Zhou Y
Oncol Rep; 2019 Aug; 42(2):717-725. PubMed ID: 31173266
[TBL] [Abstract][Full Text] [Related]
24. Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma.
Wu C; Gupta N; Huang YH; Zhang HF; Alshareef A; Chow A; Lai R
BMC Cancer; 2018 Apr; 18(1):361. PubMed ID: 29609590
[TBL] [Abstract][Full Text] [Related]
25. The PI3K/AKT/c-MYC Axis Promotes the Acquisition of Cancer Stem-Like Features in Esophageal Squamous Cell Carcinoma.
Zhang HF; Wu C; Alshareef A; Gupta N; Zhao Q; Xu XE; Jiao JW; Li EM; Xu LY; Lai R
Stem Cells; 2016 Aug; 34(8):2040-51. PubMed ID: 27144349
[TBL] [Abstract][Full Text] [Related]
26. Dual role of B7-H6 as a novel prognostic marker in hepatocellular carcinoma.
Qiu H; Gao S; Sun Z; Wang J
APMIS; 2021 Mar; 129(3):105-117. PubMed ID: 33220098
[TBL] [Abstract][Full Text] [Related]
27. Allogeneic and xenogeneic anti-tumor effect of callithrix jacchus natural killer cells is dependent on NKp30 and B7-H6 interaction.
Müller T; Schlahsa L; Zhang HJ; Skaik Y; Eiz-Vesper B; Immenschuh S; Blasczyk R; Figueiredo C
J Biol Regul Homeost Agents; 2014; 28(2):183-93. PubMed ID: 25001651
[TBL] [Abstract][Full Text] [Related]
28. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.
Kuo HY; Hsu HT; Chen YC; Chang YW; Liu FT; Wu CW
Glycobiology; 2016 Feb; 26(2):155-65. PubMed ID: 26447186
[TBL] [Abstract][Full Text] [Related]
29. The VHL tumor suppressor protein regulates tumorigenicity of U87-derived glioma stem-like cells by inhibiting the JAK/STAT signaling pathway.
Kanno H; Sato H; Yokoyama TA; Yoshizumi T; Yamada S
Int J Oncol; 2013 Mar; 42(3):881-6. PubMed ID: 23338840
[TBL] [Abstract][Full Text] [Related]
30. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.
Jiang B; Zhang T; Liu F; Sun Z; Shi H; Hua D; Yang C
Oncotarget; 2016 May; 7(22):31755-71. PubMed ID: 27145365
[TBL] [Abstract][Full Text] [Related]
31. [Research Advances of A New Co-stimulatory Molecule-B7 Homolog 6--Review].
Wu FF; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):295-8. PubMed ID: 26913440
[TBL] [Abstract][Full Text] [Related]
32. Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation.
Liu Z; Zhang W; Phillips JB; Arora R; McClellan S; Li J; Kim JH; Sobol RW; Tan M
Oncogene; 2019 Jan; 38(1):88-102. PubMed ID: 30082909
[TBL] [Abstract][Full Text] [Related]
33. BRCA1-associated protein inhibits glioma cell proliferation and migration and glioma stem cell self-renewal via the TGF-β/PI3K/AKT/mTOR signalling pathway.
Wang B; Cao C; Liu X; He X; Zhuang H; Wang D; Chen B
Cell Oncol (Dordr); 2020 Apr; 43(2):223-235. PubMed ID: 31776938
[TBL] [Abstract][Full Text] [Related]
34. Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6.
Cao G; Wang J; Zheng X; Wei H; Tian Z; Sun R
J Biol Chem; 2015 Dec; 290(50):29964-73. PubMed ID: 26472927
[TBL] [Abstract][Full Text] [Related]
35. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
36.
Liu X; Guo R; Xu Y
Genet Test Mol Biomarkers; 2021 Jul; 25(7):463-470. PubMed ID: 34280008
[No Abstract] [Full Text] [Related]
37. Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation.
Ding Z; Liu X; Liu Y; Zhang J; Huang X; Yang X; Yao L; Cui G; Wang D
Mol Carcinog; 2015 May; 54(5):405-15. PubMed ID: 24347226
[TBL] [Abstract][Full Text] [Related]
38. B7-H6 expression correlates with cancer progression and patient's survival in human ovarian cancer.
Zhou Y; Xu Y; Chen L; Xu B; Wu C; Jiang J
Int J Clin Exp Pathol; 2015; 8(8):9428-33. PubMed ID: 26464699
[TBL] [Abstract][Full Text] [Related]
39. Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions.
Matta J; Baratin M; Chiche L; Forel JM; Cognet C; Thomas G; Farnarier C; Piperoglou C; Papazian L; Chaussabel D; Ugolini S; Vély F; Vivier E
Blood; 2013 Jul; 122(3):394-404. PubMed ID: 23687088
[TBL] [Abstract][Full Text] [Related]
40. B7-H6 enhances F-actin rearrangement by targeting c-MYC activation to promote medulloblastoma migration and invasion.
Fan J; Wang Y; Liang X; Peng Y; Li S; Li X; Zhou F; Li Y
Med Oncol; 2023 Jan; 40(3):85. PubMed ID: 36692844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]